ArticleHuman vaccines & immunotherapeutics2019

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

Ruixiao Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.